Copper: Which Tests to Order Alongside

Why a Solo Copper Level Is Not Enough

A serum copper result without context is one of the most misinterpreted values in clinical chemistry. Roughly 85 to 95% of circulating copper is bound to ceruloplasmin, meaning total serum copper rises and falls with this carrier protein rather than reflecting true copper status [1]. Estrogen, pregnancy, infection, and inflammation all push ceruloplasmin up, dragging total copper along for the ride.

A 2019 review in the Journal of Trace Elements in Medicine and Biology found that serum copper alone had a sensitivity of only 56% for detecting Wilson disease when ceruloplasmin was not simultaneously measured [2]. The European Association for the Study of the Liver (EASL) Clinical Practice Guidelines state: "Serum ceruloplasmin should be determined in all patients in whom Wilson disease is suspected; a value below 0.2 g/L (20 mg/dL) strongly supports the diagnosis" [3]. Without that paired value, you cannot calculate free copper, and you cannot distinguish between copper overload, copper deficiency, and a normal result masked by an acute-phase protein spike.

The practical rule: never order serum copper without ceruloplasmin. Everything else on the paired-test list depends on clinical context.

Ceruloplasmin: The Non-Negotiable Pair

Ceruloplasmin is a ferroxidase produced in the liver that carries six copper atoms per molecule. Its reference range sits between 20 and 35 mg/dL in most laboratories [1]. Ordering it alongside copper lets you perform the free copper calculation:

Free copper (mcg/dL) = total serum copper (mcg/dL) minus (3.15 × ceruloplasmin in mg/dL)

A normal free copper result falls between 10 and 15 mcg/dL. Values above 25 mcg/dL suggest copper toxicity or Wilson disease. Values near zero or negative suggest lab error or aceruloplasminemia [4].

Low ceruloplasmin (below 20 mg/dL) paired with low total copper and high free copper is the classic Wilson disease biochemical pattern. But ceruloplasmin is also an acute-phase reactant. A patient with active hepatitis or systemic inflammation may have a "normal" ceruloplasmin that masks underlying Wilson disease. The EASL guidelines recommend repeating the test once inflammation resolves if clinical suspicion persists [3].

One often-missed scenario: ceruloplasmin drops in severe liver failure, protein-losing enteropathy, and nephrotic syndrome regardless of copper status. A low ceruloplasmin does not always mean Wilson disease. Context matters.

24-Hour Urine Copper

When the differential includes Wilson disease, copper toxicity from environmental exposure, or monitoring of chelation therapy, add a 24-hour urine copper collection. The American Association for the Study of Liver Diseases (AASLD) sets the diagnostic threshold at greater than 40 mcg per 24 hours for adults, with values exceeding 100 mcg/24 hours considered highly suggestive of Wilson disease [5].

In pediatric patients, the Leipzig scoring system assigns 2 points for 24-hour urine copper above 100 mcg and 4 points for values above the upper limit of normal after a penicillamine challenge (typically above 1 to 600 mcg/24 hours post-challenge) [3]. This remains one of the most sensitive non-genetic tests for Wilson disease in children and young adults.

Collection errors are common. Incomplete collections produce falsely low results. Instruct patients to discard the first morning void, collect every subsequent void for 24 hours, and include the final morning void. Confirm adequacy by checking 24-hour urine creatinine: adult men should excrete 14 to 26 mg/kg/day, adult women 11 to 20 mg/kg/day [6]. A creatinine value far below these ranges signals an incomplete collection.

Spot urine copper-to-creatinine ratios have been proposed as alternatives. A 2022 study in Hepatology (N=142) found that a spot ratio above 100 mcg/g creatinine had 91% sensitivity and 87% specificity for Wilson disease compared to the 24-hour collection [7]. This approach saves time but has not yet been adopted into major society guidelines.

Zinc and the Zinc-to-Copper Ratio

Zinc and copper compete for absorption via the same intestinal transporter, metallothionein. Excess zinc supplementation is one of the most common iatrogenic causes of copper deficiency, and the reverse relationship holds as well. A 2018 cross-sectional analysis of NHANES data (N=4,822) reported that adults with serum zinc below 70 mcg/dL were 2.3 times more likely to have elevated serum copper compared to those with normal zinc levels [8].

The zinc-to-copper ratio, calculated by dividing serum zinc (mcg/dL) by serum copper (mcg/dL), ideally falls between 0.7 and 1.0. Ratios below 0.7 suggest relative copper excess and have been associated in observational data with increased oxidative stress markers and cardiovascular risk, though causation is not established [9]. Ratios above 1.5 raise concern for copper depletion, particularly in patients supplementing zinc for immune support, acne, or benign prostatic hyperplasia.

Order serum zinc whenever you are investigating copper deficiency or when a patient reports zinc supplementation exceeding 40 mg/day (the tolerable upper intake level set by the National Institutes of Health Office of Dietary Supplements) [10]. The specimen handling note matters: zinc levels are falsely elevated by hemolysis and by rubber-stoppered collection tubes. Use trace-element-free (royal blue top) tubes and separate serum within 45 minutes.

Hepatic Panel: AST, ALT, ALP, and Bilirubin

Copper accumulates preferentially in the liver. By the time a patient with Wilson disease presents with neuropsychiatric symptoms, hepatic copper content typically exceeds 250 mcg per gram of dry liver tissue (normal: <50 mcg/g) [3]. A comprehensive metabolic panel (CMP) or dedicated hepatic panel captures early signals of that damage.

Dr. Michael Schilsky, Medical Director of Liver Transplantation at Yale, has noted: "Many Wilson disease patients are first identified not by a neurologist but by an internist investigating unexplained transaminase elevations in a young adult" [11]. AST and ALT elevations in Wilson disease are often modest (1.5 to 5 times the upper limit of normal) and can be mistaken for viral hepatitis or NAFLD if copper studies are not ordered. A distinctive biochemical clue is an AST-to-ALT ratio greater than 2.2 combined with alkaline phosphatase below 40 IU/L and a low serum albumin, a pattern with 94% sensitivity for Wilsonian fulminant hepatic failure according to a retrospective cohort (N=220) published in Hepatology [12].

Include direct and indirect bilirubin. Coombs-negative hemolytic anemia with elevated indirect bilirubin and suppressed haptoglobin is another signature of acute copper toxicity.

CBC with Differential

Copper is required for the function of cytochrome c oxidase and other mitochondrial enzymes in hematopoietic cells. Deficiency produces a characteristic pattern: anemia (often macrocytic or normocytic) plus neutropenia, sometimes mistaken for myelodysplastic syndrome [13].

A case series from the Mayo Clinic (N=40 patients with confirmed copper deficiency) found that 78% had anemia, 50% had neutropenia, and 22% had pancytopenia at presentation [14]. The anemia is typically refractory to iron and B12 supplementation, which is the clinical clue that triggers copper testing. Order a CBC with differential alongside copper whenever the primary indication is unexplained cytopenias, and add a reticulocyte count and peripheral smear to characterize the anemia morphology.

In copper excess (Wilson disease, acute copper poisoning), expect Coombs-negative hemolytic anemia from direct oxidative damage to red blood cell membranes. The hemolysis can be severe enough to trigger acute kidney injury from hemoglobinuria.

Iron Studies and Ferritin

Copper, iron, and ceruloplasmin are metabolically intertwined. Ceruloplasmin (also called ferroxidase) converts ferrous iron (Fe²⁺) to ferric iron (Fe³⁺), enabling iron loading onto transferrin. In copper deficiency, this conversion stalls, producing a functional iron deficiency even when iron stores are adequate [15].

The result is a confusing lab picture: low serum iron, low transferrin saturation, but normal or elevated ferritin. This pattern mimics the anemia of chronic disease. Without a serum copper level, the underlying copper deficiency goes unrecognized. A 2020 retrospective study in Blood (N=88) found that 34% of patients ultimately diagnosed with copper-deficiency anemia had received inappropriate IV iron infusions before the correct diagnosis was made [16].

Order a full iron panel (serum iron, TIBC, transferrin saturation, and ferritin) alongside copper whenever anemia is part of the clinical picture. If ferritin is normal or high but transferrin saturation is low, and the patient has risk factors for copper depletion (gastric bypass, excessive zinc use, malabsorption), copper deficiency should top the differential.

Vitamin B12 and Methylmalonic Acid

Copper deficiency causes a myelopathy that is clinically and radiographically indistinguishable from subacute combined degeneration caused by B12 deficiency. Both produce dorsal column dysfunction with impaired proprioception, spastic paraparesis, and hyperintense signal on T2-weighted MRI of the posterior spinal cord [17].

The overlap is so precise that the AASLD and the American Academy of Neurology both recommend measuring B12 (and methylmalonic acid if B12 is borderline) whenever copper deficiency myelopathy is suspected [5]. If B12 is normal but the neurologic syndrome persists, copper deficiency becomes the leading explanation. If both are low, both must be repleted.

Practical tip: B12 deficiency is far more common than copper deficiency. But the patients who have copper deficiency as the cause of their myelopathy are disproportionately post-bariatric-surgery patients and those on long-term zinc supplementation. Ask about both.

Hepatic Copper Content and Genetic Testing

When biochemical tests are equivocal (ceruloplasmin between 14 and 20 mg/dL, urine copper between 40 and 100 mcg/day, Leipzig score of 2, 3), two additional tests resolve the diagnosis.

Hepatic copper quantification via liver biopsy remains the gold standard. A value above 250 mcg/g dry weight confirms Wilson disease with high specificity. The EASL guidelines recommend this test when the Leipzig score does not reach 4 and clinical suspicion remains [3].

ATP7B gene sequencing identifies pathogenic variants in the copper-transporting ATPase responsible for Wilson disease. Over 900 mutations have been catalogued. Detection of two pathogenic variants (homozygous or compound heterozygous) is confirmatory regardless of biochemistry [18]. The test is available through commercial labs and is especially useful for family screening of first-degree relatives. A 2021 study in Genetics in Medicine (N=598) demonstrated that cascade genetic screening identified presymptomatic Wilson disease in 23% of siblings of index cases, enabling treatment before organ damage [19].

Order genetic testing when biopsy is contraindicated (coagulopathy, patient refusal) or when screening relatives. Both tests are expensive and should be reserved for cases where ceruloplasmin, urine copper, and hepatic function tests have not settled the diagnosis.

Additional Context-Dependent Panels

Several other tests pair with copper in specific clinical scenarios.

Slit-lamp examination (Kayser-Fleischer rings): Not a lab test, but the EASL guidelines list it as a required component of the Wilson disease workup. Present in 95% of patients with neurologic Wilson disease but only 50% of those with hepatic presentations [3].

Serum molybdenum: Rarely ordered but worth knowing. Molybdenum is a cofactor for sulfite oxidase and xanthine oxidase and competes with copper at the absorption level. Tetrathiomolybdate is actually used as an experimental copper-lowering agent. In patients with occupational molybdenum exposure, copper depletion can result [20].

Direct Coombs test and haptoglobin: Order when hemolytic anemia accompanies copper abnormalities. A negative Coombs test with low haptoglobin points toward copper-mediated oxidative hemolysis rather than autoimmune hemolysis.

Urinalysis: In acute copper poisoning (ingestion of copper sulfate, contaminated water), greenish-blue discoloration of urine and hemoglobinuria may be present.

Putting the Paired Panel Together

The minimum copper workup for any indication is two tests: serum copper plus ceruloplasmin. From there, expand based on the clinical question.

For suspected Wilson disease: add 24-hour urine copper, hepatic panel, CBC, slit-lamp exam, and consider ATP7B sequencing.

For suspected copper deficiency: add zinc, CBC with differential, reticulocyte count, iron panel, B12, and methylmalonic acid.

For suspected copper toxicity (non-Wilson): add 24-hour urine copper, hepatic panel, CBC, haptoglobin, direct Coombs, LDH, and urinalysis.

For routine monitoring in patients on zinc therapy for Wilson disease: serum copper, ceruloplasmin, 24-hour urine copper, zinc, hepatic panel, and CBC every 6 to 12 months per AASLD recommendations [5].

The free copper calculation (total copper minus 3.15 × ceruloplasmin) should be performed at every visit. A rising free copper on treatment signals non-adherence or disease progression. Target free copper on treatment is 5 to 15 mcg/dL [5].